- The CMS is proposing to maintain the performance threshold at 75 points for CY 2025. Scoring 75 or more points would allow an individual or group a payment bonus; scoring fewer than 75 points would result in a payment penalty in 2027.
- By law, the CMS is not proposing to change the category weights. The quality performance and cost performance categories will each be weighted at 30%. Promoting interoperability and improvement activities performance categories will maintain weighting at 25% and 15%, respectively.
- The CMS will maintain the data completeness threshold for the MIPS quality performance category at 75% for the 2025–2028 performance years. This marks a change from previous proposed rules that stated the data completeness threshold would increase to 80% in 2027.
- The CMS is proposing to add six new measures in the cost category, including rheumatoid arthritis.
- The CMS is proposing to add adult COVID-19 vaccination status to the rheumatology measure set. It is also proposing changes to four existing measures in the set.
- The CMS is proposing various changes to the Advancing Rheumatology Patient Care MVP.
ACR/ARP members should email the ACR’s advocacy team at [email protected] with any questions and comments. We will monitor the rule’s implementation and serve as an educational resource for members on its provisions and the impact they will have on rheumatology.
